Modelling the impact of atherosclerosis on drug release and distribution from coronary stents

C.M. McKittrick, S. Kennedy, K. G. Oldroyd, S. McGinty, C. McCormick

Research output: Contribution to journalArticle

15 Citations (Scopus)
117 Downloads (Pure)

Abstract

Although drug-eluting stents (DES) are now widely used for the treatment of coronary heart disease, there remains considerable scope for the development of enhanced designs which address some of the limitations of existing devices. The drug release profile is a key element governing the overall performance of DES. The use of in vitro, in vivo, ex vivo, in silico and mathematical models has enhanced understanding of the factors which govern drug uptake and distribution from DES. Such work has identified the physical phenomena determining the transport of drug from the stent and through tissue, and has highlighted the importance of stent coatings and drug physical properties to this process. However, there is limited information regarding the precise role that the atherosclerotic lesion has in determining the uptake and distribution of drug. In this review, we start by discussing the various models that have been used in this research area, highlighting the different types of information they can provide. We then go on to describe more recent methods that incorporate the impact of atherosclerotic lesions.
Original languageEnglish
Pages (from-to)477-487
Number of pages11
JournalAnnals of Biomedical Engineering
Volume44
Issue number2
DOIs
Publication statusPublished - 18 Sep 2015

Fingerprint

Stents
Drug-Eluting Stents
Atherosclerosis
Pharmaceutical Preparations
Physical Phenomena
Computer Simulation
Coronary Disease
Theoretical Models
Equipment and Supplies
Physical properties
Drug Liberation
Tissue
Mathematical models
Coatings
Research

Keywords

  • coronary artery disease
  • atherosclerosis
  • drug-eluting stent
  • drug delivery
  • arteries
  • computational models
  • drug distribution
  • drug transport
  • drug uptake
  • in vitro models
  • in vivo models

Cite this

McKittrick, C.M. ; Kennedy, S. ; Oldroyd, K. G. ; McGinty, S. ; McCormick, C. / Modelling the impact of atherosclerosis on drug release and distribution from coronary stents. In: Annals of Biomedical Engineering . 2015 ; Vol. 44, No. 2. pp. 477-487.
@article{a3d12947d9a8401baf79f4900e0fc9c1,
title = "Modelling the impact of atherosclerosis on drug release and distribution from coronary stents",
abstract = "Although drug-eluting stents (DES) are now widely used for the treatment of coronary heart disease, there remains considerable scope for the development of enhanced designs which address some of the limitations of existing devices. The drug release profile is a key element governing the overall performance of DES. The use of in vitro, in vivo, ex vivo, in silico and mathematical models has enhanced understanding of the factors which govern drug uptake and distribution from DES. Such work has identified the physical phenomena determining the transport of drug from the stent and through tissue, and has highlighted the importance of stent coatings and drug physical properties to this process. However, there is limited information regarding the precise role that the atherosclerotic lesion has in determining the uptake and distribution of drug. In this review, we start by discussing the various models that have been used in this research area, highlighting the different types of information they can provide. We then go on to describe more recent methods that incorporate the impact of atherosclerotic lesions.",
keywords = "coronary artery disease, atherosclerosis, drug-eluting stent, drug delivery, arteries, computational models, drug distribution, drug transport , drug uptake, in vitro models, in vivo models",
author = "C.M. McKittrick and S. Kennedy and Oldroyd, {K. G.} and S. McGinty and C. McCormick",
note = "The final publication is available at Springer via http://dx.doi.org/10.1007/s10439-015-1456-7",
year = "2015",
month = "9",
day = "18",
doi = "10.1007/s10439-015-1456-7",
language = "English",
volume = "44",
pages = "477--487",
journal = "Annals of Biomedical Engineering",
issn = "0090-6964",
number = "2",

}

Modelling the impact of atherosclerosis on drug release and distribution from coronary stents. / McKittrick, C.M.; Kennedy, S.; Oldroyd, K. G.; McGinty, S.; McCormick, C.

In: Annals of Biomedical Engineering , Vol. 44, No. 2, 18.09.2015, p. 477-487.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modelling the impact of atherosclerosis on drug release and distribution from coronary stents

AU - McKittrick, C.M.

AU - Kennedy, S.

AU - Oldroyd, K. G.

AU - McGinty, S.

AU - McCormick, C.

N1 - The final publication is available at Springer via http://dx.doi.org/10.1007/s10439-015-1456-7

PY - 2015/9/18

Y1 - 2015/9/18

N2 - Although drug-eluting stents (DES) are now widely used for the treatment of coronary heart disease, there remains considerable scope for the development of enhanced designs which address some of the limitations of existing devices. The drug release profile is a key element governing the overall performance of DES. The use of in vitro, in vivo, ex vivo, in silico and mathematical models has enhanced understanding of the factors which govern drug uptake and distribution from DES. Such work has identified the physical phenomena determining the transport of drug from the stent and through tissue, and has highlighted the importance of stent coatings and drug physical properties to this process. However, there is limited information regarding the precise role that the atherosclerotic lesion has in determining the uptake and distribution of drug. In this review, we start by discussing the various models that have been used in this research area, highlighting the different types of information they can provide. We then go on to describe more recent methods that incorporate the impact of atherosclerotic lesions.

AB - Although drug-eluting stents (DES) are now widely used for the treatment of coronary heart disease, there remains considerable scope for the development of enhanced designs which address some of the limitations of existing devices. The drug release profile is a key element governing the overall performance of DES. The use of in vitro, in vivo, ex vivo, in silico and mathematical models has enhanced understanding of the factors which govern drug uptake and distribution from DES. Such work has identified the physical phenomena determining the transport of drug from the stent and through tissue, and has highlighted the importance of stent coatings and drug physical properties to this process. However, there is limited information regarding the precise role that the atherosclerotic lesion has in determining the uptake and distribution of drug. In this review, we start by discussing the various models that have been used in this research area, highlighting the different types of information they can provide. We then go on to describe more recent methods that incorporate the impact of atherosclerotic lesions.

KW - coronary artery disease

KW - atherosclerosis

KW - drug-eluting stent

KW - drug delivery

KW - arteries

KW - computational models

KW - drug distribution

KW - drug transport

KW - drug uptake

KW - in vitro models

KW - in vivo models

UR - http://www.scopus.com/inward/record.url?scp=84942036890&partnerID=8YFLogxK

UR - http://link.springer.com/journal/volumesAndIssues/10439

UR - http://www.scopus.com/inward/record.url?scp=84942036890&partnerID=8YFLogxK

U2 - 10.1007/s10439-015-1456-7

DO - 10.1007/s10439-015-1456-7

M3 - Article

VL - 44

SP - 477

EP - 487

JO - Annals of Biomedical Engineering

JF - Annals of Biomedical Engineering

SN - 0090-6964

IS - 2

ER -